Equities

Shanghai INT Medical Instruments Co Ltd

Shanghai INT Medical Instruments Co Ltd

Actions
  • Price (HKD)27.25
  • Today's Change0.00 / 0.00%
  • Shares traded4.00k
  • 1 Year change+1.11%
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai INT Medical Instruments Co Ltd, formerly Shanghai Kindly Medical Instruments Co Ltd, is a China-based company principally engaged in the research, development, production and sales of intracardiac interventional devices. The Company operates its businesses through two segments. The Intracardiac Interventional Business segment is mainly engaged in the sales, manufacturing and research and development of intracardiac interventional medical devices and related molds, standard parts and masks. The Other segment is engaged in the research and development of other interventional medical devices, such as neurointerventional medical devices and heart valve implantable medical devices. The Company mainly operates its businesses in the domestic market and overseas markets.

  • Revenue in HKD (TTM)812.53m
  • Net income in HKD168.86m
  • Incorporated2006
  • Employees1.57k
  • Location
    Shanghai INT Medical Instruments Co LtdNo.925 Jinyuan One RoadJiading DistrictSHANGHAI ChinaCHN
  • Phone+86 2 159140056
  • Fax+86 2 169000013
  • Websitehttps://www.int-medical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.